Lipoprotein receptor-related protein-6 protects the brain from ischemic injury

Stroke

Volumn 44, Issue 8, 2013, Pages 2284-2291

  Abe, Takato ^a   Zhou, Ping ^a   Jackman, Katherine ^a   Capone, Carmen ^a   Casolla, Barbara ^a   Hochrainer, Karin ^a   Kahles, Timo ^a   Ross, Margaret Elizabeth ^a   Anrather, Josef ^a   Iadecola, Costantino ^a  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

Author keywords

cerebral ischemia; glycogen synthase kinase 3; mitochondria; stroke; Wnt signaling pathway

Indexed keywords

BETA CATENIN; CALCIUM; GLYCOGEN SYNTHASE KINASE 3BETA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PHOSPHOSPECIFIC ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CARDIOVASCULAR PARAMETERS; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CYTOSOL; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HAPLOINSUFFICIENCY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOTOR PERFORMANCE; MOUSE; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN FUNCTION; REDUCTION; WESTERN BLOTTING;

CEREBRAL ISCHEMIA; GLYCOGEN-SYNTHASE-KINASE-3; MITOCHONDRIA; STROKE; WNT SIGNALING PATHWAY;

ANIMALS; BEHAVIOR, ANIMAL; BETA CATENIN; BRAIN; BRAIN ISCHEMIA; GLYCOGEN SYNTHASE KINASE 3; INFLAMMATION; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; MICE; MITOCHONDRIA; MOTOR ACTIVITY; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84880785734     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001320     Document Type: Article

References (37)

1. Freese JL, Pino D, Pleasure SJ. Wnt signaling in development and disease. Neurobiol Dis. 2010;38:148-153.
2. Dugo L, Collin M, Thiemermann C. Glycogen synthase kinase 3beta as a target for the therapy of shock and infammation. Shock. 2007;27:113-123. (Pubitemid 46105826)
3. Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006;126:955-968. (Pubitemid 44310775)
4. Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM, et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell. 2007;131:980-993. (Pubitemid 350138081)
5. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. 2004;113:1535-1549. (Pubitemid 39071677)
6. Zhou P, Qian L, Zhou T, Iadecola C. Mitochondria are involved in the neurogenic neuroprotection conferred by stimulation of cerebellar fasti-gial nucleus. J Neurochem. 2005;95:221-229. (Pubitemid 41384440)
7. Hirsch T, Marzo I, Kroemer G. Role of the mitochondrial permeability transition pore in apoptosis. Biosci Rep. 1997;17:67-76. (Pubitemid 27267593)
8. Cappuccio I, Calderone A, Busceti CL, Biagioni F, Pontarelli F, Bruno V, et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death. J Neurosci. 2005;25:2647-2657. (Pubitemid 40365176)
9. Mastroiacovo F, Busceti CL, Biagioni F, Moyanova SG, Meisler MH, Battaglia G, et al. Induction of the Wnt antagonist, Dickkopf-1, contributes to the development of neuronal death in models of brain focal ischemia. J Cereb Blood Flow Metab. 2009;29:264-276.
10. Schulte G, Bryja V. The Frizzled family of unconventional G-protein-coupled receptors. Trends Pharmacol Sci. 2007;28:518-525. (Pubitemid 47488504)
11. De Ferrari G V, Papassotiropoulos A, Biechele T, Wavrant De-Vrieze F, Avila ME, Major MB, et al. Common genetic variation within the low-density lipoprotein receptor-related protein 6 and late-onset Alzheimer's disease. Proc Natl Acad Sci USA. 2007;104:9434-9439. (Pubitemid 47185797)
12. Mani A, Radhakrishnan J, Wang H, Mani A, Mani MA, Nelson-Williams C, et al. LRP6 mutation in a family with early coronary disease and metabolic risk factors. Science. 2007;315:1278-1282. (Pubitemid 46364265)
13. Pinson KI, Brennan J, Monkley S, Avery BJ, Skarnes WC. An LDL-receptor-related protein mediates Wnt signalling in mice. Nature. 2000;407:535-538.
14. Cho S, Park EM, Febbraio M, Anrather J, Park L, Racchumi G, et al. The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia. J Neurosci. 2005;25:2504-2512. (Pubitemid 40365160)
15. Abe T, Kunz A, Shimamura M, Zhou P, Anrather J, Iadecola C. The neuroprotective effect of prostaglandin E2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic. J Cereb Blood Flow Metab. 2009;29:66-72.
16. Kunz A, Abe T, Hochrainer K, Shimamura M, Anrather J, Racchumi G, et al. Nuclear factor-kappaB activation and postischemic infammation are suppressed in CD36-null mice after middle cerebral artery occlusion. J Neurosci. 2008;28:1649-1658. (Pubitemid 351287045)
17. Kawano T, Anrather J, Zhou P, Park L, Wang G, Frys KA, et al. Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neuro-toxicity. Nat Med. 2006;12:225-229. (Pubitemid 43214750)
18. Park L, Anrather J, Zhou P, Frys K, Pitstick R, Younkin S, et al. NADPH-oxidase-derived reactive oxygen species mediate the cerebro-vascular dysfunction induced by the amyloid beta peptide. J Neurosci. 2005;25:1769-1777. (Pubitemid 40279282)
19. Abe T, Shimamura M, Jackman K, Kurinami H, Anrather J, Zhou P, et al. Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia. Stroke. 2010;41:898-904.
20. Liu D, Lu C, Wan R, Auyeung WW, Mattson MP. Activation of mito-chondrial ATP-dependent potassium channels protects neurons against ischemia-induced death by a mechanism involving suppression of Bax translocation and cytochrome c release. J Cereb Blood Flow Metab. 2002;22:431-443. (Pubitemid 34273599)
21. Valerio A, Bertolotti P, Delbarba A, Perego C, Dossena M, Ragni M, et al. Glycogen synthase kinase-3 inhibition reduces ischemic cerebral damage, restores impaired mitochondrial biogenesis and prevents ROS production. J Neurochem. 2011;116:1148-1159.
22. Brooks SP, Dunnett SB. Tests to assess motor phenotype in mice: a user's guide. Nat Rev Neurosci. 2009;10:519-529.
23. Doble BW, Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci. 2003;116:1175-1186. (Pubitemid 36410657)
24. Endo H, Nito C, Kamada H, Nishi T, Chan PH. Activation of the Akt/GSK3beta signaling pathway mediates survival of vulnerable hippocam-pal neurons after transient global cerebral ischemia in rats. J Cereb Blood Flow Metab. 2006;26:1479-1489. (Pubitemid 44809077)
25. Koh SH, Yoo AR, Chang DI, Hwang SJ, Kim SH. Inhibition of GSK-3 reduces infarct volume and improves neurobehavioral functions. Biochem Biophys Res Commun. 2008;371:894-899.
26. Mi K, Dolan PJ, Johnson GV. The low density lipoprotein receptor-related protein 6 interacts with glycogen synthase kinase 3 and attenuates activity. J Biol Chem. 2006;281:4787-4794. (Pubitemid 43847740)
27. Piao S, Lee SH, Kim H, Yum S, Stamos JL, Xu Y, et al. Direct inhibition of GSK3beta by the phosphorylated cytoplasmic domain of LRP6 in Wnt/beta-catenin signaling. PLoS One. 2008;3:e4046.
28. Gimenez-Cassina A, Lim F, Cerrato T, Palomo GM, Diaz-Nido J. Mitochondrial hexokinase II promotes neuronal survival and acts downstream of glycogen synthase kinase-3. J Biol Chem. 2009;284:3001-3011.
29. Iadecola C. Cyclooxygenase-2 and stroke: the long and short of it. Ann Neurol. 2003;54:141-142. (Pubitemid 36909610)
30. Ikeda-Matsuo Y, Ota A, Fukada T, Uematsu S, Akira S, Sasaki Y. Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc Natl Acad Sci USA. 2006;103:11790-11795. (Pubitemid 44182529)
31. Chong ZZ, Maiese K. Targeting WNT, protein kinase B, and mitochon-drial membrane integrity to foster cellular survival in the nervous system. Histol Histopathol. 2004;19:495-504. (Pubitemid 38443910)
32. Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796-808.
33. Cortés-Vieyra R, Bravo-Patiño A, Valdez-Alarcón JJ, Juárez MC, Finlay BB, Baizabal-Aguirre VM. Role of glycogen synthase kinase-3 beta in the infammatory response caused by bacterial pathogens. J Infamm (Lond). 2012;9:23.
34. Sims NR, Muyderman H. Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta. 2010;1802:80-91.
35. Joiner DM, Ke J, Zhong Z, Xu HE, Williams BO. LRP5 and LRP6 in development and disease. Trends Endocrinol Metab. 2013;24:31-39.
36. Liu W, Singh R, Choi CS, Lee HY, Keramati AR, Samuel VT, et al. Low density lipoprotein (LDL) receptor-related protein 6 (LRP6) regulates body fat and glucose homeostasis by modulating nutrient sensing pathways and mitochondrial energy expenditure. J Biol Chem. 2012;287:7213-7223.
37. Rey JP, Ellies DL. Wnt modulators in the biotech pipeline. Dev Dyn. 2010;239:102-114.